Patent EP-2534951-A1 (EP)
Inventor: ANDERSCH WOLFRAM DR
IPC: C12N15/82
Filed: 2008-04-14
Abstract: Transgenic plant production potential utilization involves utilizing a plant with an effective quantity of a mixture of a compound having general formula (I) and another compound. The latter compound is selected from acetylcholinesterase inhibitors, gamma-aminobutyric acid-controlled chloride channel antagonist, sodium channel modulators or voltage-dependent sodium channel blockers, nicotine acetylcholine receptor agonist, allosteric acetylcholine receptor modulators, chloride channel activators, oxidative phosphorylation inhibitors, buprofezin, chitin biosynthesis inhibitors. The latter compound is selected from ecdysone agonist, octopaminergic agonist, electron transport inhibitor, fatty acid biosynthesis inhibitor, benclothiaz, methyl bromide, chloropicrin, sulfuryl fluoride, cryolite, pymetrozine, pyrifluquinazon, flonicamid, clofentezine, hexythiazox, etoxazole, chlorfenapyr, dinobuton, dinocap, Bacillus thuringiensis strain, cyromazine, amitraz, hydramethylnon, acequinocyl, fluacrypyrim, cyflumetofen, cyenopyrafen, bifenazate, flubendiamide, bromopropylate, chinomethionat, chlordimeform, chlorobenzilate, clothiazoben, cycloprene, dicofol, dicyclanil, fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure, japonilure, sulfluramid, tetrasul, triarathene, 4-(((6-bromo-pyridin-3-yl) methyl)(2-fluoroethyl)amino)furan-2-(5H)-one, 4-(((6-chloro-pyridin-3-yl)methyl)(2-fluoro-ethyl) mino)furan-2-(5H)-one, 4-(((6-chloro-5-fluoro-pyridin-3-yl) methyl)(methyl) amino)furan-2-(5H)-one, 1-(6-chloro pyridin-3-yl)ethyl (methyl)oxido-lambda 4 sulfanylidencyanamide, 1-(6-chloro-pyridin-3-yl)ethyl (methyl)oxido-lambda 4 sulfanylidencyanamide or its diastereomer having general formula (II, III), 6-(trifluormethyl-pyridin-3-yl)methyl (methyl)oxido-lambda 4-sulfanylidencyanamide or 1-(6-trifluoro-methylpyridin-3-yl)ethyl (methyl)oxido-lambda4-sulfanylidencyanamide or its diastereomer having general formula (IV,V). The compounds with general formulae (I-V). R1 : chlorine or cyano group. ORGANIC CHEMISTRY - Preferred Compounds: The acetylcholinesterase inhibitor is selected from carbamates or organophosphates.The carbamate is selected from alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, bendiocarb, benfuracarb, bufencarb, butacarb, butocarboxim, carbaryl, carbofuran, carbosulfan, cloethocarb, dimetilan, ethiofencarb, fenobucarb, fenothiocarb, formetanate, furathiocarb, isoprocarb, metam sodium, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, promecarb, propoxur, thiodicarb, thiofanox, trimethacarb or xylylcarb. The organophosphate is selected from a total of 89 compounds (Claimed), acephate, azamethiphos, azinphos (-methyl, -ethyl), bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chlorethoxyfos, chlorfenvinphos, chlormephos, coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-S-methyl, demeton-S-methyl sulfone, dialifos, diazinon, dichlofenthion, dichlorvos, dicrotophos, dimethoate, dimethylvinphos dioxabenzofos, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate, heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isoxathion, malathion, mecarbam, methacrifos, methamidophos, methidathion, monocrotophos, naled or omethoate. The gamma-aminobutyric acid-controlled chloride channel antagonist is selected from camphechlor, chlordane, endosulfan, gamma-hexachlorocyclohexane, hexachlorocyclohexane, hepta chlorine, lindane, methoxychlor, acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole or vaniliprole. The sodium channel modulator or voltage-dependent sodium channel blocker is selected from acrinathrin, allethrin, beta-cyfluthrin, bifenthrin, bioallethrin, bioallethrin-S-cyclopentyl isomer, bioethanomethrin, biopermethrin, bioresmethrin, chlovaporthrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta-), cyphenothrin, deltamethrin, empenthrin (1R)isomer, esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin, fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumethrin, fluvalinate, fubfenprox, gamma cyhalothrin, imiprothrin, lambda cyhalothrin, metofluthrin, permethrin, phenothrin (1R-trans isomer), prallethrin, profluthrin, protrifenbute, pyresmethrin, resmethrin, silafluofen, fluvalinate, tefluthrin, terallethrin, tetramethrin (1R isomer), tralomethrin, transfluthrin, pyrethrin, dichloro-diphenyl-trichloroethane or methoxychlor The nicotine acetylcholine receptor agonist is selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, imidaclothiz, nitenpyram, nithiazine, thiacloprid, thiamethoxam, nicotine, bensultap, cartap or thiosultap sodium. The allosteric acetylcholine receptor modulator is spinosyn selected from spinosad or spinetoram. The chloride channel activator is selected from abamectin, emamectin, emamectin benzoate, ivermectin, lepimectin, milbemectin, hydroprene, kinoprene, methoprene, epofenonane, triprene, fenoxycarb, pyriproxifen or diofenolan. The oxidative phosphorylation inhibitor is selected from diafenthiuron, azocyclotin, cyhexatin fenbutatin oxides, propargite or tetradifon. The chitin biosynthesis inhibitor is selected from bistrifluron, chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron or triflumuron. The ecdysone agonist is selected from chromafenozide, halofenozide, methoxyfenozide, tebufenozide, fufenozide or azadirachtin. The electron transport inhibitor is selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad, rotenone, indoxacarb or metaflumizone. The fatty acid biosynthesis inhibitor is selected from spirodiclofen, spiromesifen or spirotetramat. [Image] [Image] [Image] [Image] [Image].